【摘要】 目的:探讨三腔胃肠管在老年消化道恶性肿瘤病人手术后EEN的应用价值。方法:选取28例老年消化道恶性肿瘤病人,术后给予EEN,分为单腔普通营养管(胃肠减压管+鼻肠管)组和经鼻置三腔胃肠管组。术后48h开始给予以瑞能为主的EN,对比置管成功率、病人出现呕吐、腹泻等不耐受情况的比例、达到预期营养目标的比例、感染发生率等,并在第8天复查肝、肾功能,评价三腔胃肠管在老年消化道恶性肿瘤病人术后的应用价值。结果:三腔胃肠管在胃肠减压的同时,还可进行EN,降低了并发症的发生率;采用瑞能进行EEN未发现严重不良反应。结论:老年消化道恶性肿瘤病人术后采用三腔胃肠管进行的EEN安全可行。更多还原

【Abstract】 Objective: To evaluate the application values of EEN with a new three-lumen gastrojejunaltube(Freka Trelumina,FT) after the abdominal malignant operation to elder patients.Methods: 28 elder patients with abdominal malignant operation were expected to require EEN after operation.Patients received EEN via one-lumen tubes(nasojejunal + nasogastric,14 patients,control group) or a FT tube(14 patients).All patients were given EEN with Supportan on the 3rd day after the operation.The successful rate of placing tubes,the intolerance of feeding,the rate of vomiting and diarrhea,the reaching rate of target nutrition,and the incidence of pneumonia were observed.Renal and Liver functions were examined on the 8th day after operation.Results: The patients were feeded by new three-lumen gastrojejunal tube with simultaneous decompression of stomach.There were fewer and lighter symptoms in FT groups.No evidence of damage of the renal and liver function due to EEN was found.Conclusion: EEN with FT after the abdominal malignant operation is feasible and safe in elder patients.更多还原